Moderna CEO Stephane Bancel: Could take weeks for more clarity on omicron Covid variant

Subscribe to The Global Herald in Google News

CNBC Television published this video item, entitled “Moderna CEO Stephane Bancel: Could take weeks for more clarity on omicron Covid variant” – below is their description.

Moderna CEO Stephane Bancel sits down with CNBC’s Meg Tirrell and the ‘Squawk Box’ team to discuss how the company is responding to the omicron coronavirus variant.

CNBC Television YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


Subscribe to The Global Herald in Google News

Similar Content

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • Jim Cramer says he would be a buyer of Disney following Netflix-related weakness
  • Streaming of older music supplants current artists
  • Vegas residencies bring big payoffs to entertainers
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Global National: Jan. 21, 2022 | Little hope for a diplomatic solution for Ukraine-Russia situation
  • Data shows Covid may be in retreat
  • The West Block: Jan. 23, 2021 | Defence minister on Ukraine support, Alberta premier discusses COVID
  • COVID-19 boosters 90% effective in preventing hospitalization: CDC
  • CDC Data Shows Covid Booster Shots Highly Protective
  • In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • Boosters Effectively Fend Off Delta, Omicron Variants in Studies
  • Zoom, Moderna, Docusign become worst performing Nasdaq stocks
  • COVID-19: Moderna CEO hopeful for COVID and flu combo vaccine in the future
  • COVID-19: Vaccine efficacy against Omicron underscores need for boosters
  • Covid Pandemic May Shift to Endemic in 2022, Moderna Chair Says
  • Leave a Comment

    We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.

    Posting....